2,2,3,3-tetrafluoro-1-propanol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 6441 |
| SCHEMBL ID | 22399 |
| MeSH ID | M0509883 |
| Synonym |
|---|
| 1h,1h,3h-tetrafluoro-1-propanol |
| 2,2,3,3-tetrafluoro-1-propanol |
| 2,2,3,3-tetrafluoropropyl alcohol |
| brn 1738264 |
| 2,2,3,3-tetrafluoropropan-1-ol |
| tetrafluoropropyl alcohol |
| 1-propanol, 2,2,3,3-tetrafluoro- |
| 2,2,3,3-tetrafluoropropanol |
| 1,1,3-trihydroperfluoro-1-propanol |
| einecs 200-955-5 |
| nsc 113 |
| ai3-23784 |
| 1,3-trihydroperfluoro-1-propanol |
| wln: q1xffyff |
| nsc113 |
| 2,3,3-tetrafluoro-1-propanol |
| 76-37-9 |
| 2,3,3-tetrafluoropropyl alcohol |
| 1-propanol,2,3,3-tetrafluoro- |
| nsc-113 |
| 2,2,3,3-tetrafluoro-1-propanol, 98% |
| T0101 |
| STK802056 |
| AKOS000120480 |
| 1-hydroxy-2,2,3,3-tetrafluoropropane |
| unii-rno513716p |
| rno513716p , |
| BP-11316 |
| FT-0609077 |
| .alpha.,.alpha.,.omega.-trihydroperfluoropropanol |
| 1,1,2,2-tetrafluoro-3-hydroxypropane |
| 2,2,3,3-tetrafluoropropanol-1 |
| 2,2,3,3-tetrafluoro-1-propanol [mi] |
| c3-fluoroalcohol |
| BBL027472 |
| SCHEMBL22399 |
| hcf2cf2ch2oh |
| chf2cf2ch2oh |
| DTXSID8058796 |
| W-104366 |
| 2,2,3,3-tetrafluoro-propanol-1 |
| mfcd00004676 |
| AT23334 |
| CS-W013420 |
| Q23978438 |
| AMY6795 |
| qgjnlzuaszxage-uhfffaoysa-n |
| EN300-20158 |
| Z104477086 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (22.13) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||